DEC 06, 2018 06:00 AM CET

Overview of the main hormones associated with alteration of bone and mineral metabolism in patients with chronic kidney disease

SPONSORED BY: DiaSorin
C.E. CREDITS: P.A.C.E. CE | Florida CE
Speakers
  • Ex head of Laboratoire d'explorations fonctionnelles hôpital Necker-Enfants malades
    Biography
      Now retired (but still active), JCS was the chief of the hormone laboratory in the department of Physiology of the University Necker-Enfants malades hospital in Paris, France, and an invited professor at the Liège University, Belgium. Its main research/clinical topics were the growth hormone/IGFI axis and all aspects of bone and mineral metabolism. He also focused on the importance of vitamin D in many disease other than bone and mineral diseases. He has published more than 300 papers in peer-reviewed journal that are referenced in Pubmed. He was an active member of the scientific committee of the French group of research and information on osteoporosis (GRIO) and a member of the editorial board of several journals.

    Abstract:
    DATE: December 6, 2018
    TIME:  6:00am PST, 9:00am EST, 3:00pm CET
     
    Alterations in the bone and mineral metabolism is of great concern in patients with chronic kidney disease (CKD). As the glomerular filtration rate (GFR) decreases, phosphatemia tends to increase while the renal secretion of the active vitamin D metabolite decreases with, consequently, increases in both serum PTH and FGF23 levels. This the pathophysiological basis of the so-called CKD-bone and mineral disorders (MBD). Experts in Nephrology have published international guidelines, called the KDIGO/CKD-MBD, to help the colleagues to deal with these disorders. In this webinar, the KDIGO recommendations concerning the measurement of the serum concentration of PTH, vitamin D metabolites and FGF23 will be discussed.
     
    Learning Objective:
    • Understand the bone metabolic disorder in CKD patients
    • Which is the mechanism that regulate the calcium and phosphorus absorption in patient with altered hormone activities
    • Know the utility of a few fundamental markers to decide the CKD patient management

    Show Resources
    You May Also Like
    SEP 05, 2019 04:00 PM CEST
    C.E. CREDITS
    SEP 05, 2019 04:00 PM CEST
    DATE: September 5, 2019TIME: 7:00am PT, 10:00am ET, 4:00pm CEST PCR (Polymerase Chain Reaction) has gone through a massive evolution since its development in 1983. Besides it...
    JUN 05, 2019 05:00 PM CEST
    C.E. CREDITS
    JUN 05, 2019 05:00 PM CEST
    DATE: June 5, 2019TIME: 8:00am PDT, 11:00am EDT, 5:00pm CEST Eukaryotic cell cultures respond to the most subtle influence. Apart from the risk of contamination, minimal chan...
    AUG 27, 2019 09:00 AM PDT
    C.E. CREDITS
    AUG 27, 2019 09:00 AM PDT
    DATE: August 27, 2019 TIME: 9:00am PDT, 12:00pm EDT Immunotherapies targeting PD-1 or PD-L1 have proven remarkably effective for treating cancer in some patients, with considerabl...
    JUN 19, 2019 10:00 AM PDT
    JUN 19, 2019 10:00 AM PDT
    DATE: June 19, 2019TIME: 10:00am PDT, 1:00pm EDT As we develop new methods to create more biologically relevant models for research in understanding disease etiology and in...
    OCT 02, 2019 11:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    OCT 02, 2019 11:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    DATE: October 2, 2019TIME: 11:00am PDT, 2:00pm EDT Ditch the Excel spreadsheets and manage your molecular workflows entirely in your LIMS Achieve configuration of molecular workf...
    MAY 16, 2019 04:00 PM CEST
    C.E. CREDITS
    MAY 16, 2019 04:00 PM CEST
    DATE: May 16, 2019TIME: 7:00am PDT, 10:00am EDT, 4:00pm CEST The emergence of NGS is revolutionizing the microbiological sciences and transforming medicine. Deep sequencing has...
    Loading Comments...
    Show Resources